Greiner Bio-One Launches New Erlenmeyer Shaker Flask Product Line in North America

MONROE, N.C.--(BUSINESS WIRE)-- Greiner Bio-One North America Inc.  is proud to announce the launch of a new line of Erlenmeyer Shaker Flasks. These flasks are a welcomed new addition to the already robust cell culture product grouping provided by Greiner Bio-One which provides pharmaceutical and research laboratories with all the products they would need to perform cell culture applications.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180830005802/en/

Ernlenmeyer Shaker Flasks from Greiner Bio-One (Photo: Business Wire)

Greiner Bio-One Erlenmeyer shaker flasks are ideal for suspension culture of mammalian cells, plants, microbes and microorganisms. The shaker flasks feature a patented 2-in-1 DuoCAP^® which allows for flexibility between vented and non-vented applications. Each flask is manufactured utilizing an optically clear, inert polycarbonate resin which can be disposed of after single use or be made reusable when autoclaved.

Products within this new product line range from 125 mL to 3000mL capacity and are available with flat or baffled bottoms to suit the needs of the customer. For additional information regarding this product, customers are encouraged to visit the Greiner Bio-One website or contact their Account Manager.

Greiner Bio-One North America, Inc., located in Monroe, North Carolina, provides product manufacturing, distribution logistics and product application support to clinical laboratories, research laboratories at Universities, startup companies, and to the world’s largest hospitals, Pharmaceutical and Biotechnology corporations. Greiner Bio-One’s products offer solutions for the collection of human samples and plastic labware products specifically related to the medical research field.

For more information about Greiner Bio-One North America, please visit http://www.gbo.com/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180830005802/en/